Cyclooxygenase-2 Expression : A Significant Prognostic Indicator for Patients With Colorectal Cancer Labile

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pilot study of celecoxib and infusional 5‐fluorouracil as second‐line treatment for advanced pancreatic carcinoma

  2004cited by this paper
• Elevated Cyclooxygenase-2 Expression Is Associated with Altered Expression of p53 and SMAD4, Amplification of HER-2/neu, and Poor Outcome in Serous Ovarian Carcinoma

  2004cited by this paper
• Cyclooxygenase-2 expression in colorectal cancer liver metastases

  2004cited by this paper
• Cyclooxygenase-1 and -2 in human testicular tumours.

  2003cited by this paper
• Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis.

  2003cited by this paper
• Combination of a COX-2 Inhibitor With Radiotherapy or Radiochemotherapy in the Treatment of Thoracic Cancer

  2003cited by this paper
• Cyclo‐oxygenase‐2 over‐expression in sporadic colorectal carcinoma without lymph node involvement

  2003cited by this paper
• Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma.

  2003cited by this paper
• Cyclooxygenase-2 Expression as a New Marker for Patients with Colorectal Cancer.

  2003cited by this paper
• Elevated expression of cyclooxygenase‐2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma

  2003cited by this paper
• The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases.

  2003cited by this paper
• Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer.

  2003cited by this paper
• Changes in Colorectal Cancer During a 20-Year Period: An Extended Report From the Multi-Institutional Registry of Large Bowel Cancer, Japan

  2003cited by this paper
• Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.

  2003cited by this paper
• Increased toxicity and lack of efficacy of Rofecoxib in combination with chemotherapy for treatment of metastatic colorectal cancer: A phase II study

  2003cited by this paper
• Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.

  2003cited by this paper
• A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients.

  2003cited by this paper
• Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis.

  2003cited by this paper
• A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

  2003cited by this paper
• Cyclooxygenase‐2 expression during carcinogenesis in the human stomach

  2002cited by this paper
• COX-2 expression in rectal carcinoma: immunohistochemical pattern and clinical outcome.

  2002cited by this paper
• Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus.

  2002cited by this paper
• Expression of cyclooxygenase-2 protein in colorectal carcinomas

  2002cited by this paper
• Cyclooxygenase 2- and prostaglandin E2 receptor EP2-dependent angiogenesis in ApcΔ716 mouse intestinal polyps

  2002cited by this paper
• Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma

  2002cited by this paper
• Many actions of cyclooxygenase‐2 in cellular dynamics and in cancer

  2002cited by this paper
• Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer

  2002cited by this paper
• Guidelines 2000 for colon and rectal cancer surgery.

  2001cited by this paper
• Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.

  2001cited by this paper
• Association of Enhanced Cyclooxygenase-2 Expression With Possible Local Immunosuppression in Human Colorectal Carcinomas

  2001cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer.

  2001cited by this paper
• Advances in Brief Genetic Disruption of Ptgs-1 , as well as of Ptgs-2 , Reduces Intestinal Tumorigenesis in Min Mice

  2000cited by this paper
• Localization of cyclooxygenase-2 in human sporadic colorectal adenomas.

  2000cited by this paper
• Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer

  2000cited by this paper
• Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients.

  2000influential reference
• Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas.

  1999cited by this paper
• Cyclooxygenase regulates angiogenesis induced by colon cancer cells.

  1998cited by this paper
• Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas.

  1998cited by this paper
• Prognostic factors in colorectal cancer

  1998cited by this paper
• Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

  1998cited by this paper
• Aspirin use and potential mechanisms for colorectal cancer prevention.

  1997cited by this paper
• Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

  1997cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Expression of cyclooxygenase-1 and -2 in human colorectal cancer.

  1995cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.

  1995cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper
• Aspirin use and reduced risk of fatal colon cancer.

  1992cited by this paper
• A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

  1991cited by this paper
• ALTERATIONS IN THE

  1985cited by this paper

• Expression and significance of cyclooxygenase-2 in colorectal cancer and the colorectal adenomas tissue

  2016cites this paper
• The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma.

  2008cites this paper
• COX-2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapy

  2007cites this paper